Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 28,202 | 17,935 | 8,725 | 3,049 | 13,556 |
| Depreciation Amortization | 23,082 | 15,720 | 9,724 | 4,737 | 19,514 |
| Income taxes - deferred | 3,069 | 0 | N/A | N/A | -1,130 |
| Accounts receivable | -10,390 | -5,122 | -4,986 | -3,628 | 7,243 |
| Other Working Capital | -3,055 | -2,780 | -2,988 | -8 | 1,322 |
| Other Operating Activity | 1,516 | -726 | 2,307 | 2,272 | -9,707 |
| Operating Cash Flow | $42,424 | $25,027 | $12,782 | $6,422 | $30,798 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -174,908 | -81,681 | -23,233 | -17,789 | -7,684 |
| Sale Of Investment | 12,367 | 12,367 | 12,367 | 5,275 | 5,840 |
| Other Investing Activity | 5,333 | 4,049 | 2,847 | 1,425 | 5,532 |
| Investing Cash Flow | $-157,208 | $-65,265 | $-8,019 | $-11,089 | $3,688 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 135,800 | 67,800 | 29,200 | 21,000 | 15,000 |
| Debt Issued | N/A | N/A | N/A | N/A | 11,345 |
| Debt Repayment | N/A | -3,326 | -2,264 | -1,141 | -4,559 |
| Common Stock Issued | 22,353 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -43,133 | -27,303 | -40,200 | -22,000 | -70,793 |
| Financing Cash Flow | $115,020 | $37,171 | $-13,264 | $-2,141 | $-49,007 |
| Exchange Rate Effect | -335 | -206 | -593 | -218 | 478 |
| Beginning Cash Position | 14,492 | 14,492 | 14,492 | 14,492 | 28,535 |
| End Cash Position | 14,393 | 11,219 | 5,398 | 7,466 | 14,492 |
| Net Cash Flow | $-99 | $-3,273 | $-9,094 | $-7,026 | $-14,043 |
| Free Cash Flow | |||||
| Operating Cash Flow | 42,424 | 25,027 | 12,782 | 6,422 | 30,798 |
| Capital Expenditure | -206,830 | -104,986 | -40,345 | -25,770 | -31,353 |
| Free Cash Flow | -164,406 | -79,959 | -27,563 | -19,348 | -555 |